| Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2013: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Outline of Final Research Achievements |
It is said Japan has approximately 9 million diabetics (including the person that diabetes is strongly soubted and the person who can not deny possibility of diabetes)(The National Health and Mutririon Survey in Japan), and there is a person receiving an injection of insulin and/or treated for oral diabetic agents, but the thing which a patient of approximately 80% takes in medicine is medicine called the incretin now. The incretin medications have not only I a state of diabetes better but also various action (potection of heart and/or kidney). I found the finding in vitro that the action which may improve periodontal disease and pulpitis to the medicine.
|
